Insights · Start here
How do you keep one approved message true across audiences and languages?
Why does message drift happen?
One approved message becomes dozens of pieces: a press release, a patient leaflet, a physician email, an investor line, social posts, a spokesperson's answer, versions in other languages. Every adaptation is a chance to drift, and the drift is rarely deliberate. It happens in small, natural-sounding edits:
- a qualifier is dropped to make a sentence shorter ("in adults with…" disappears);
- a population quietly widens;
- an association becomes a cause;
- "improved" becomes "better than";
- an investigational product is described as if it were approved;
- a safety statement becomes an absolute.
Each of those edits can look like good copywriting. Each of them can become a new claim.
What is a message fingerprint?
A message fingerprint captures an approved message in two halves.
The semantic half: what it says. The claim itself, its numbers, its scope and its qualifiers. "Reduced symptom scores by a stated amount at week six, in adults with a stated condition" has a claim, a figure, a time point and a population, and each of them is part of the fingerprint.
The pragmatic half: what it does. The same words do different jobs in different places. The pragmatic half records the approved use of the message: the market, the audience, the channel, the locale, where the product is in its lifecycle, the intended use and the type of material. It also protects the job the message is approved to do: to inform rather than compare, and to describe rather than promise.
A check that looks only at the words misses this. The pragmatic half is what tells you that a sentence approved for a physician audience is not automatically approved for a consumer post, and that a sentence approved as information is not approved as a comparison.
What counts as "saying more" versus "saying less"?
The rule that makes adaptation safe is directional:
| Edit | Example | Verdict |
|---|---|---|
| Drop a statistic, keep the meaning | A symptom-score figure becomes "helped manage core symptoms" | Allowed: it says less |
| Simplify a mechanism for patients | A receptor name becomes "works on brain signals linked to the condition" | Allowed, if the approved set supports it |
| Drop a required qualifier | "In adults with…" is removed | Needs a read at minimum; blocked if it matches a recorded forbidden version or reads as a broader claim |
| Widen the population | "Adults with…" becomes "people with…" | Not allowed: it says more |
| Add a comparison | "Improved" becomes "works better than other treatments" | Not allowed: a new claim |
| Add certainty | "May help" becomes "will help" | Not allowed: a new claim |
All examples are illustrative.
Saying less is what adaptation is. Saying more is a new claim, and new claims go back to the people who approve claims.
How do you anticipate drift before it happens?
The most useful step is to write down the forbidden versions of a message at the moment it is approved, not after a reviewer catches one. For each approved statement, the likely wrong versions follow predictable shifts: a dropped qualifier, a broadened population, a causal claim, a comparison, a superlative, a regulatory status the product does not have, a stronger evidence tier, a guarantee, commercial overreach, a safety absolute.
Once those forbidden versions exist, a draft that reproduces one word for word can be stopped outright. Anything less clear-cut, such as a claim that may have been abstracted too far, goes to a person marked as needing a read rather than being silently blocked or silently passed.
How does this work across languages and channels?
A version in another language, or for another channel, is checked the same way as any other version: its locale and channel are part of its context, and each claim in it is checked against the approved set. Two practical points:
- Locale is part of approved use. A message approved for one market is not automatically approved for another, even in perfect translation, because labels and rules differ between markets.
- Short channels compress. A social post or a headline has less room for qualifiers, which is exactly where required elements go missing. Compressed formats deserve a stricter read, not a looser one.
Each version should also remember where it came from. When a version carries the identity of the approved message it was derived from, a reviewer can trace any sentence back to its source, and when the approved message changes, every version built on the old one can be marked out of date instead of living on.
What should still go to a human?
Everything that is a judgment. Fingerprinting and claim checks remove the obvious failures and organize the rest; they do not replace the medical, legal and regulatory reviewers who approve claims. A well-built system is honest about that boundary: its highest verdict for machine-made work is ready for human review.
Why not just measure how similar the new version is to the approved one?
Because similarity measures topic, not meaning. In our own tests, a cure claim scored closer to an approved release than real, faithful published adaptations did. The full evidence is in Similarity is not compliance.
How does CommsRx approach it?
CommsRx keeps approved statements in its Library, each with its proof points, its approved use and its forbidden versions, written when the statement is admitted. When Ally adapts a message, every version is checked against the approved set: a version may say less, never more; a word-for-word forbidden version is blocked; anything uncertain reaches the communications lead marked "needs a read." Each version carries its parent, so the lineage can be walked back to the approved source. CommsRx calls this patent-pending message fingerprinting by meaning.
Related questions
About this page
Drafted with AI assistance from CommsRx's own product records, then edited and checked by Abhi Basu, founder of CommsRx and Signal Fidelity Group. Last reviewed October 19, 2026. Corrections: help@signalfidelitygroup.com.